Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
November 2009
Features
Health Care and Law
Mandatory Vaccination of Health Care Workers
Whose Rights Should Come First?
Despite government recommendations that health care professionals be vaccinated against the H1N1 influenza in order to protect patients, a significant number of workers intend to refuse the vaccine. Dr. Field reviews the legal status of the mandates for vaccination as well as viewpoints for and against compliance.
Robert I. Field, JD, MPH, PhD
Humor
What’s in a Name?
These days, it seems that just about everyone is emotionally attached to a brand-name electronic device, a designer T-shirt, or a gym bag with a pharma logo. The author, a reluctant consumer, ponders the power of brands.
Nancy Greengold, MD, MBA
Q & A
An Interview Series with Members of the ASHP Expert Panel on Formulary Management
Part 1: Linda S. Tyler, PharmD
In the first of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
C. Lee Ventola, MS
Meeting Highlights
American Society for Bone and Mineral Research
Agents for postmenopausal osteoporosis are reviewed.
Walter Alexander
FDA Public Health Alert
Heparin Revisions
A Call for Heightened Vigilance and Monitoring
As a result of the contamination of unfractionated heparin, changes in the product’s potency have been made to ensure its purity and safety.
Walter Alexander
Pharmaceutical Approval Update
Topics include pralatrexate (Folotyn) for lymphoma; telavancin (Vibativ) for skin infections; and bepotastine besilate (Bepreve), an eyedrop for conjunctivitis.
Marvin M. Goldenberg, PhD, RPh, MS
Departments
Editorial
Take Back Our Profession
David B. Nash, MD, MBA, recounts his talk to physicians-in-training on the topics of professionalism and responsibility.
David B. Nash, MD, MBA
Medication Errors
Patient Safety Brochures
What Do They Really Say about Safety?
Matthew Grissinger, RPh, FASCP, emphasizes the importance of providing appropriate safety tips in brochures for patients.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Hospital Pharmacists Worry about Definition of ‘Meaningful Use’
Will They Be Eligible for Federal Electronic Health Record Grants?
Stephen Barlas discusses the challenges faced by hospitals in meeting the criteria for “meaningful use” when installing health information technology.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From Berinert to Votrient, P&T presents the latest studies and information about FDA approvals, recalls, and industry updates.
Drug Forecast
Iloperidone (Fanapt): An FDA-Approved Treatment Option for Schizophrenia
Authors Montes and Rey review iloperidone (Fanapt) for the treatment of schizophrenia.
Amy Barbara Montes, PharmD, and Jose A. Rey, PharmD, BCPP
